SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
This Quarter Return
+0.94%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$1.14B
AUM Growth
+$1.14B
(+9.2%)
Cap. Flow
+$90.2M
Cap. Flow
% of AUM
7.92%
Top 10 Holdings %
Top 10 Hldgs %
83.73%
Holding
130
New
23
Increased
19
Reduced
34
Closed
19
Top Buys
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
$107M |
| 2 |
Simplify High Yield ETF
CDX
|
$89.5M |
| 3 |
Simplify MBS ETF
MTBA
|
$44.5M |
| 4 |
Schwab US TIPS ETF
SCHP
|
$31.5M |
| 5 |
UnitedHealth
UNH
|
$5.96M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$157M |
| 2 |
Intuitive Surgical
ISRG
|
$7.57M |
| 3 |
Cigna
CI
|
$6.41M |
| 4 |
Align Technology
ALGN
|
$6.31M |
| 5 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$4.87M |
Sector Composition
| 1 | Healthcare | 15.39% |
| 2 | Energy | 2.27% |
| 3 | Industrials | 0.86% |
| 4 | Technology | 0.53% |
| 5 | Real Estate | 0.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares Core S&P 500 ETF
IVV
$662B
| $384M | 25.77% | 702,365 -287,115 | -29% | -$157M |
|
|
2
iShares Core US Aggregate Bond ETF
AGG
$131B
| $164M | 11.02% | 1,692,591 +1,101,573 | +186% | +$107M |
|
3
Simplify Aggregate Bond ETF
AGGH
$319M
| $102M | 6.82% | 4,896,741 | – | – |
|
|
4
Simplify High Yield ETF
CDX
$358M
| $92.9M | 6.23% | 4,045,997 +3,896,143 | +2,600% | +$89.5M |
|
5
Simplify Stable Income ETF
BUCK
$348M
| $79.2M | 5.31% | 3,216,098 +36,419 | +1% | +$897K |
|
|
6
Simplify MBS ETF
MTBA
$1.43B
| $44.5M | 2.99% | +884,453 | New | +$44.5M |
|
|
7
Schwab US TIPS ETF
SCHP
$13.9B
| $31.5M | 2.11% | +605,686 | New | +$31.5M |
|
8
Plains GP Holdings
PAGP
$3.82B
| $25.8M | 1.73% | 1,372,360 | – | – |
|
9
Sarepta Therapeutics
SRPT
$1.78B
| $16.5M | 1.11% | 104,536 +14,013 | +15% | +$2.21M |
|
10
Applied Therapeutics
APLT
$71M
| $13.2M | 0.88% | 2,817,505 | – | – |
|
11
Eli Lilly
LLY
$657B
| $10.3M | 0.69% | 11,412 +3,371 | +42% | +$3.05M |
|
|
12
UnitedHealth
UNH
$281B
| $6.93M | 0.46% | 13,600 +11,700 | +616% | +$5.96M |
|
|
13
Intuitive Surgical
ISRG
$170B
| $6.82M | 0.46% | 15,338 -17,010 | -53% | -$7.57M |
|
14
Regeneron Pharmaceuticals
REGN
$61.5B
| $6.68M | 0.45% | 6,360 +3,310 | +109% | +$3.48M |
|
15
Madrigal Pharmaceuticals
MDGL
$9.76B
| $6.53M | 0.44% | 23,313 +19 | +0.1% | +$5.32K |
|
16
Merck
MRK
$210B
| $6.35M | 0.43% | 51,302 +3,639 | +8% | +$451K |
|
17
PureCycle Technologies
PCT
$2.57B
| $6.27M | 0.42% | 1,058,392 -6,048 | -0.6% | -$35.8K |
|
18
Boston Scientific
BSX
$156B
| $6.13M | 0.41% | 79,639 +17,181 | +28% | +$1.32M |
|
19
TScan Therapeutics
TCRX
$102M
| $6.12M | 0.41% | 1,046,916 | – | – |
|
20
Akero Therapeutics
AKRO
$3.74B
| $5.76M | 0.39% | 245,487 -189 | -0.1% | -$4.43K |
|
21
Novo Nordisk
NVO
$251B
| $5.63M | 0.38% | +39,427 | New | +$5.63M |
|
22
Phathom Pharmaceuticals
PHAT
$864M
| $5.38M | 0.36% | 521,935 | – | – |
|
23
Avidity Biosciences
RNA
$5.99B
| $5.11M | 0.34% | 125,000 | – | – |
|
24
Thermo Fisher Scientific
TMO
$186B
| $4.55M | 0.3% | 8,224 -47 | -0.6% | -$26K |
|
25
Ardelyx
ARDX
$1.53B
| $4.43M | 0.3% | 598,000 +248,000 | +71% | +$1.84M |
|